Fingerprint
Dive into the research topics of 'IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
Thomas A. MacE, Reena Shakya, Jason R. Pitarresi, Benjamin Swanson, Christopher W. McQuinn, Shannon Loftus, Emily Nordquist, Zobeida Cruz-Monserrate, Lianbo Yu, Gregory Young, Xiaoling Zhong, Teresa A. Zimmers, Michael C. Ostrowski, Thomas Ludwig, Mark Bloomston, Tanios Bekaii-Saab, Gregory B. Lesinski
Research output: Contribution to journal › Article › peer-review
190
Scopus
citations